COMMONWEALTH OF AUSTRALIA
NATIONAL HEALTH ACT 1953
PHARMACEUTICAL BENEFITS
DECLARATION UNDER SUB-SECTION 85(2AA)
No. PB5 of 1990
I, MARGARET NONA FORD, Principal Advisor, Health Care Access Division, Department of Community Services and Health and Delegate of the Minister of State for Community Services and Health, pursuant to sub-section 85(2AA) of the National Health Act 1953, hereby make the following Declaration:
1. This Declaration shall come into operation on 1 August 1990.
2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.
THE SCHEDULE
Ampicillin Trihydrate with Purified Water B.P.
Chloral Hydrate
Chlorpromazine
Clopamide
Diloxanide Furoate
Fenoterol Hydrobromide
Lindane
“Locasol New Formula”
Primaquine Phosphate
Sulphafurazole
Testosterone Propionate
Tetracycline Hydrochloride with a buffering agent and Nystatin
Tetracycline Hydrochloride with Nystatin
Thiopropazate Hydrochloride
Dated this twenty-fifth day of July 1990.
MARGARET FORD
PRINCIPAL ADVISOR
HEALTH CARE ACCESS DIVISION
DEPARTMENT OF COMMUNITY SERVICES AND HEALTH
DELEGATE OF THE MINISTER OF STATE FOR COMMUNITY SERVICES AND HEALTH